Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02791204 · ClinicalTrials.gov registry record
SPECT/CT Imaging of Skeletal Muscle Perfusion
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 34
- Enrollment target
NCT02791204: Completed study, sponsored by Yale University.
NCT02791204 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 34 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02791204 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
Study Summary
This study will use SPECT/CT imaging to assess the effect of percutaneous revascularization treatments in patients with Peripheral arterial disease and diabetes mellitus, in whom the disease can progress more quickly than in patients without diabetes.
Interventions
- DEVICE SPECT/CT imaging following revascularization procedures
- DEVICE SPECT/CT imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2016-05 |
| Est. Completion | 2026-01-30 |
What the finished NCT02791204 record still lists
NCT02791204 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 34 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which SPECT/CT imaging following revascularization procedures is the first listed.
NCT02791204 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02791204 about?
NCT02791204 is a clinical study titled "SPECT/CT Imaging of Skeletal Muscle Perfusion". This study will use SPECT/CT imaging to assess the effect of percutaneous revascularization treatments in patients with Peripheral arterial disease and diabetes mellitus, in whom the disease can progress more quickly than in patients without diabetes.
What is the current status of trial NCT02791204?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2016-05. Estimated completion is 2026-01-30.
What interventions are being tested in trial NCT02791204?
The interventions under investigation include: SPECT/CT imaging following revascularization procedures (DEVICE), SPECT/CT imaging (DEVICE).
Who is sponsoring clinical trial NCT02791204?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia